327 results on '"Ooi EE"'
Search Results
102. Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection.
- Author
-
Yau C, Gan ES, Kwek SS, Tan HC, Ong EZ, Hamis NZ, Rivino L, Chan KR, Watanabe S, Vasudevan SG, and Ooi EE
- Subjects
- Animals, Antibodies, Neutralizing blood, Antibodies, Neutralizing immunology, Antibodies, Viral blood, Antibodies, Viral immunology, Cell Line, Disease Models, Animal, Epididymis pathology, Epididymis virology, Female, Humans, Immunization, Leukocytes, Mononuclear immunology, Leukocytes, Mononuclear metabolism, Male, Mice, Neutralization Tests, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets metabolism, Testis immunology, Testis pathology, Testis virology, Vaccines, Attenuated administration & dosage, Viral Vaccines administration & dosage, Zika Virus immunology, Zika Virus Infection virology, Immunity, Cellular, Immunity, Humoral, Vaccines, Attenuated immunology, Viral Vaccines immunology, Zika Virus Infection immunology, Zika Virus Infection prevention & control
- Abstract
Background: The emergence of Zika virus (ZIKV) as an important cause of congenital and childhood developmental disorders presents another challenge to global health. Efforts to develop a Zika vaccine have begun although vaccine development against flaviviruses, of which ZIKV belongs to, has proven to be time-consuming and challenging. Defining the vaccine attributes that elicit adaptive immune response necessary for preventing ZIKV infection could provide an evidence-based guide to Zika vaccine development., Methods: We used a previously described attenuated ZIKV DN-2 strain in a type-I interferon receptor deficient mouse model and tested the hypothesis that duration of vaccine burden rather than peak level of infection, is a determinant of immunogenicity. We quantified both humoral and cellular responses against ZIKV using plaque reduction neutralisation test and flow cytometry with ELISPOT assays, respectively. Vaccinated mice were challenged with wild-type ZIKV (H/PF/2013 strain) to determine the level of protection against infection., Findings: We found that the overall vaccine burden is directly correlated with neutralising antibody titres. Reduced duration of vaccine burden lowered neutralising antibody titres that resulted in subclinical infection, despite unchanged peak vaccine viraemia levels. We also found that sterilising immunity is dependant on both neutralising antibody and CD8
+ T cell responses; depletion of CD8+ T cells in vaccinated animals led to wild-type ZIKV infection, especially in the male reproductive tract., Interpretation: Our findings indicate that duration of attenuated virus vaccine burden is a determinant of humoral and cellular immunity and also suggest that vaccines that elicit both arms of the adaptive immune response are needed to fully prevent ZIKV transmission., Funding: This study was supported by the National Medical Research Council through the Clinician-Scientist Award (Senior Investigator) to E.E.O. Salary support for S.W. was from a Competitive Research Programme grant awarded by the National Research Foundation of Singapore., Competing Interests: Declaration of Competing Interest E.E.O and S.S.K. have an issued patent titled “Rapid method of generating live attenuated vaccines” (Singapore patent publication number: 10201602980W), which includes the Zika virus strain DN-2 used in this study. The authors declare no other competing interests., (Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
103. Disentangling etiologies of CNS infections in Singapore using multiple correspondence analysis and random forest.
- Author
-
Zellweger RM, Yacoub S, Chan YFZ, Soon D, Shafi H, Ooi ST, Chan M, Jacobson L, Sessions OM, Vincent A, Low JGH, Ooi EE, Wang L, Wijaya L, and Tan K
- Subjects
- Aged, Central Nervous System Infections microbiology, Communicable Diseases classification, Communicable Diseases epidemiology, Communicable Diseases etiology, Data Interpretation, Statistical, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Singapore epidemiology, Antigens, Bacterial analysis, Antigens, Fungal analysis, Antigens, Viral analysis, Central Nervous System Infections complications, Communicable Diseases diagnosis
- Abstract
Central nervous system (CNS) infections cause substantial morbidity and mortality worldwide, with mounting concern about new and emerging neurologic infections. Stratifying etiologies based on initial clinical and laboratory data would facilitate etiology-based treatment rather than relying on empirical treatment. Here, we report the epidemiology and clinical outcomes of patients with CNS infections from a prospective surveillance study that took place between 2013 and 2016 in Singapore. Using multiple correspondence analysis and random forest, we analyzed the link between clinical presentation, laboratory results, outcome and etiology. Of 199 patients, etiology was identified as infectious in 110 (55.3%, 95%-CI 48.3-62.0), immune-mediated in 10 (5.0%, 95%-CI 2.8-9.0), and unknown in 79 patients (39.7%, 95%-CI 33.2-46.6). The initial presenting clinical features were associated with the prognosis at 2 weeks, while laboratory-related parameters were related to the etiology of CNS disease. The parameters measured were helpful to stratify etiologies in broad categories, but were not able to discriminate completely between all the etiologies. Our results suggest that while prognosis of CNS is clearly related to the initial clinical presentation, pinpointing etiology remains challenging. Bio-computational methods which identify patterns in complex datasets may help to supplement CNS infection diagnostic and prognostic decisions.
- Published
- 2020
- Full Text
- View/download PDF
104. Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes.
- Author
-
Gan ES, Tan HC, Le DHT, Huynh TT, Wills B, Seidah NG, Ooi EE, and Yacoub S
- Subjects
- Adolescent, Adult, Cell Hypoxia, Cell Line, Child, Cholesterol metabolism, Dengue etiology, Drug Resistance, Viral, Female, Hepatocytes metabolism, Hepatocytes virology, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Male, Myeloid Cells metabolism, Myeloid Cells virology, Proprotein Convertase 9 blood, Receptors, LDL metabolism, Young Adult, Antiviral Agents pharmacology, Dengue drug therapy, Dengue metabolism, Dengue Virus pathogenicity, Proprotein Convertase 9 metabolism
- Abstract
Dengue virus (DENV) infection requires cholesterol as a proviral factor, although statin treatment did not show antiviral efficacy in patients with dengue. Here, we show that DENV infection manipulated cholesterol metabolism in cells residing in low-oxygen microenvironments (hypoxia) such as in the liver, spleen, and lymph nodes. DENV infection induced expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), which reduces low-density lipoprotein receptor (LDLR) recycling and hence cholesterol uptake. We found that, whereas LDLR uptake would have distributed cholesterol throughout the various cell compartments, de novo cholesterol synthesis enriched this lipid in the endoplasmic reticulum (ER). With cholesterol enrichment in the ER, ER-resident STING and type I IFN (IFN) activation was repressed during DENV infection. Our in vitro findings were further supported by the detection of elevated plasma PCSK9 levels in patients with dengue with high viremia and increased severity of plasma leakage. Our findings therefore suggest that PCSK9 plays a hitherto unrecognized role in dengue pathogenesis and that PCSK9 inhibitors could be a suitable host-directed treatment for patients with dengue.
- Published
- 2020
- Full Text
- View/download PDF
105. Asymptomatic SARS-CoV-2 infection.
- Author
-
Ooi EE and Low JG
- Subjects
- COVID-19, Humans, SARS-CoV-2, Seroconversion, Betacoronavirus, Coronavirus Infections, Pandemics, Pneumonia, Viral, Ships
- Published
- 2020
- Full Text
- View/download PDF
106. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
- Author
-
Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, Chng MHY, Lin M, Tan N, Linster M, Chia WN, Chen MI, Wang LF, Ooi EE, Kalimuddin S, Tambyah PA, Low JG, Tan YJ, and Bertoletti A
- Subjects
- Betacoronavirus chemistry, COVID-19, Case-Control Studies, Coronavirus Infections virology, Coronavirus Nucleocapsid Proteins, Cross Reactions immunology, Humans, Immunodominant Epitopes immunology, Nucleocapsid Proteins chemistry, Nucleocapsid Proteins immunology, Pandemics, Phosphoproteins, Pneumonia, Viral virology, SARS-CoV-2, Betacoronavirus immunology, Coronavirus Infections immunology, Pneumonia, Viral immunology, Severe Acute Respiratory Syndrome immunology, T-Lymphocytes immunology
- Abstract
Memory T cells induced by previous pathogens can shape susceptibility to, and the clinical severity of, subsequent infections
1 . Little is known about the presence in humans of pre-existing memory T cells that have the potential to recognize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we studied T cell responses against the structural (nucleocapsid (N) protein) and non-structural (NSP7 and NSP13 of ORF1) regions of SARS-CoV-2 in individuals convalescing from coronavirus disease 2019 (COVID-19) (n = 36). In all of these individuals, we found CD4 and CD8 T cells that recognized multiple regions of the N protein. Next, we showed that patients (n = 23) who recovered from SARS (the disease associated with SARS-CoV infection) possess long-lasting memory T cells that are reactive to the N protein of SARS-CoV 17 years after the outbreak of SARS in 2003; these T cells displayed robust cross-reactivity to the N protein of SARS-CoV-2. We also detected SARS-CoV-2-specific T cells in individuals with no history of SARS, COVID-19 or contact with individuals who had SARS and/or COVID-19 (n = 37). SARS-CoV-2-specific T cells in uninfected donors exhibited a different pattern of immunodominance, and frequently targeted NSP7 and NSP13 as well as the N protein. Epitope characterization of NSP7-specific T cells showed the recognition of protein fragments that are conserved among animal betacoronaviruses but have low homology to 'common cold' human-associated coronaviruses. Thus, infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein. Understanding how pre-existing N- and ORF1-specific T cells that are present in the general population affect the susceptibility to and pathogenesis of SARS-CoV-2 infection is important for the management of the current COVID-19 pandemic.- Published
- 2020
- Full Text
- View/download PDF
107. Preventing Dengue Epidemics during the COVID-19 Pandemic.
- Author
-
Wilder-Smith A, Tissera H, Ooi EE, Coloma J, Scott TW, and Gubler DJ
- Subjects
- Animals, Betacoronavirus, COVID-19, Community Participation, Culicidae virology, Humans, Mosquito Control, Pandemics, Public Health, SARS-CoV-2, Tropical Climate, Coronavirus Infections epidemiology, Dengue prevention & control, Pneumonia, Viral epidemiology
- Published
- 2020
- Full Text
- View/download PDF
108. Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human Antibody.
- Author
-
Low JG, Ng JHJ, Ong EZ, Kalimuddin S, Wijaya L, Chan YFZ, Ng DHL, Tan HC, Baglody A, Chionh YH, Lee DCP, Budigi Y, Sasisekharan R, and Ooi EE
- Subjects
- Adult, Antibodies, Monoclonal, Humanized adverse effects, Antibodies, Monoclonal, Humanized pharmacokinetics, Dose-Response Relationship, Drug, Double-Blind Method, Half-Life, Humans, Kaplan-Meier Estimate, Viremia drug therapy, Yellow Fever virology, Yellow fever virus drug effects, Antibodies, Monoclonal, Humanized administration & dosage, Yellow Fever drug therapy, Yellow Fever Vaccine, Yellow fever virus immunology
- Abstract
Background: Insufficient vaccine doses and the lack of therapeutic agents for yellow fever put global health at risk, should this virus emerge from sub-Saharan Africa and South America., Methods: In phase 1a of this clinical trial, we assessed the safety, side-effect profile, and pharmacokinetics of TY014, a fully human IgG1 anti-yellow fever virus monoclonal antibody. In a double-blind, phase 1b clinical trial, we assessed the efficacy of TY014, as compared with placebo, in abrogating viremia related to the administration of live yellow fever vaccine (YF17D-204; Stamaril). The primary safety outcomes were adverse events reported 1 hour after the infusion and throughout the trial. The primary efficacy outcome was the dose of TY014 at which 100% of the participants tested negative for viremia within 48 hours after infusion., Results: A total of 27 healthy participants were enrolled in phase 1a, and 10 participants in phase 1b. During phase 1a, TY014 dose escalation to a maximum of 20 mg per kilogram of body weight occurred in 22 participants. During phases 1a and 1b, adverse events within 1 hour after infusion occurred in 1 of 27 participants who received TY014 and in none of the 10 participants who received placebo. At least one adverse event occurred during the trial in 22 participants who received TY014 and in 8 who received placebo. The mean half-life of TY014 was approximately 12.8 days. At 48 hours after the infusion, none of the 5 participants who received the starting dose of TY014 of 2 mg per kilogram had detectable YF17D-204 viremia; these participants remained aviremic throughout the trial. Viremia was observed at 48 hours after the infusion in 2 of 5 participants who received placebo and at 72 hours in 2 more placebo recipients. Symptoms associated with yellow fever vaccine were less frequent in the TY014 group than in the placebo group., Conclusions: This phase 1 trial of TY014 did not identify worrisome safety signals and suggested potential clinical benefit, which requires further assessment in a phase 2 trial. (Funded by Tysana; ClinicalTrials.gov number, NCT03776786.)., (Copyright © 2020 Massachusetts Medical Society.)
- Published
- 2020
- Full Text
- View/download PDF
109. Oxygen: viral friend or foe?
- Author
-
Gan ES and Ooi EE
- Subjects
- Cell Hypoxia, Humans, Oxygen physiology, Virus Diseases physiopathology, Viruses pathogenicity
- Abstract
The oxygen levels organ and tissue microenvironments vary depending on the distance of their vasculature from the left ventricle of the heart. For instance, the oxygen levels of lymph nodes and the spleen are significantly lower than that in atmospheric air. Cellular detection of oxygen and their response to low oxygen levels can exert a significant impact on virus infection. Generally, viruses that naturally infect well-oxygenated organs are less able to infect cells under hypoxic conditions. Conversely, viruses that infect organs under lower oxygen tensions thrive under hypoxic conditions. This suggests that in vitro experiments performed exclusively under atmospheric conditions ignores oxygen-induced modifications in both host and viral responses. Here, we review the mechanisms of how cells adapt to low oxygen tensions and its impact on viral infections. With growing evidence supporting the role of oxygen microenvironments in viral infections, this review highlights the importance of factoring oxygen concentrations into in vitro assay conditions. Bridging the gap between in vitro and in vivo oxygen tensions would allow for more physiologically representative insights into viral pathogenesis.
- Published
- 2020
- Full Text
- View/download PDF
110. Sequential immunization induces strong and broad immunity against all four dengue virus serotypes.
- Author
-
Hou J, Shrivastava S, Loo HL, Wong LH, Ooi EE, and Chen J
- Abstract
A major challenge in dengue vaccine development is the need to induce immunity against four dengue (DENV) serotypes. Dengvaxia®, the only licensed dengue vaccine, consists of four variant dengue antigens, one for each serotype. Three doses of immunization with the tetravalent vaccine induced only suboptimal protection against DENV1 and DENV2. Furthermore, vaccination paradoxically and adversely primes dengue naïve subjects to more severe dengue. Here, we have tested whether sequential immunization induces stronger and broader immunity against four DENV serotypes than tetravalent-formulated immunization. Mice were immunized with four DNA plasmids, each encoding the pre-membrane and envelope from one DENV serotype, either sequentially or simultaneously. The sequential immunization induced significantly higher levels of interferon (IFN)γ- or tumor necrosis factor (TNF)α-expressing CD4
+ and CD8+ T cells to both serotype-specific and conserved epitopes than tetravalent immunization. Moreover, sequential immunization induced higher levels of neutralizing antibodies to all four DENV serotypes than tetravalent vaccination. Consistently, sequential immunization resulted in more diversified immunoglobulin repertoire, including increased complementarity determining region 3 (CDR3) length and more robust germinal center reactions. These results show that sequential immunization offers a simple approach to potentially overcome the current challenges encountered with tetravalent-formulated dengue vaccines., Competing Interests: Competing interestsThe authors declare no competing interests., (© The Author(s) 2020.)- Published
- 2020
- Full Text
- View/download PDF
111. The Lancet Commission on dengue and other Aedes-transmitted viral diseases.
- Author
-
Wilder-Smith A, Lindsay SW, Scott TW, Ooi EE, Gubler DJ, and Das P
- Subjects
- Animals, Delivery of Health Care, Integrated organization & administration, Dengue epidemiology, Dengue prevention & control, Dengue transmission, Epidemics, Global Health statistics & numerical data, Humans, Mosquito Control methods, Vector Borne Diseases epidemiology, Vector Borne Diseases transmission, Aedes virology, Mosquito Vectors, Vector Borne Diseases prevention & control
- Published
- 2020
- Full Text
- View/download PDF
112. A Dynamic Immune Response Shapes COVID-19 Progression.
- Author
-
Ong EZ, Chan YFZ, Leong WY, Lee NMY, Kalimuddin S, Haja Mohideen SM, Chan KS, Tan AT, Bertoletti A, Ooi EE, and Low JGH
- Subjects
- Adult, Aged, Biological Variation, Individual, COVID-19, Cluster Analysis, Coronavirus Infections blood, Coronavirus Infections pathology, Cytokines blood, Gene Expression Regulation, Humans, Male, Pandemics, Pneumonia, Viral blood, Pneumonia, Viral pathology, Transcriptome, Up-Regulation, Coronavirus Infections genetics, Coronavirus Infections immunology, Pneumonia, Viral genetics, Pneumonia, Viral immunology
- Abstract
The inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to underpin COVID-19 pathogenesis. We conducted daily transcriptomic profiling of three COVID-19 cases and found that the early immune response in COVID-19 patients is highly dynamic. Patient throat swabs were tested daily for SARS-CoV-2, with the virus persisting for 3 to 4 weeks in all three patients. Cytokine analyses of whole blood revealed increased cytokine expression in the single most severe case. However, most inflammatory gene expression peaked after respiratory function nadir, except expression in the IL1 pathway. Parallel analyses of CD4 and CD8 expression suggested that the pro-inflammatory response may be intertwined with T cell activation that could exacerbate disease or prolong the infection. Collectively, these findings hint at the possibility that IL1 and related pro-inflammatory pathways may be prognostic and serve as therapeutic targets for COVID-19. This work may also guide future studies to illuminate COVID-19 pathogenesis and develop host-directed therapies., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
113. Positive epistasis between viral polymerase and the 3' untranslated region of its genome reveals the epidemiologic fitness of dengue virus.
- Author
-
Syenina A, Vijaykrishna D, Gan ES, Tan HC, Choy MM, Siriphanitchakorn T, Cheng C, Vasudevan SG, and Ooi EE
- Subjects
- A549 Cells, Dengue epidemiology, Epistasis, Genetic, Exoribonucleases, Gene Knockout Techniques, Genome, Viral, HEK293 Cells, Host-Pathogen Interactions, Humans, Interferon Type I metabolism, Microtubule-Associated Proteins, Mutation, Puerto Rico epidemiology, Virus Replication, 3' Untranslated Regions genetics, Dengue virology, Dengue Virus genetics, Viral Nonstructural Proteins genetics
- Abstract
Dengue virus (DENV) is a global health threat, causing repeated epidemics throughout the tropical world. While low herd immunity levels to any one of the four antigenic types of DENV predispose populations to outbreaks, viral genetic determinants that confer greater fitness for epidemic spread is an important but poorly understood contributor of dengue outbreaks. Here we report that positive epistasis between the coding and noncoding regions of the viral genome combined to elicit an epidemiologic fitness phenotype associated with the 1994 DENV2 outbreak in Puerto Rico. We found that five amino acid substitutions in the NS5 protein reduced viral genomic RNA (gRNA) replication rate to achieve a more favorable and relatively more abundant subgenomic flavivirus RNA (sfRNA), a byproduct of host 5'-3' exoribonuclease activity. The resulting increase in sfRNA relative to gRNA levels not only inhibited type I interferon (IFN) expression in infected cells through a previously described mechanism, but also enabled sfRNA to compete with gRNA for packaging into infectious particles. We suggest that delivery of sfRNA to new susceptible cells to inhibit type I IFN induction before gRNA replication and without the need for further de novo sfRNA synthesis could form a "preemptive strike" strategy against DENV., Competing Interests: The authors declare no competing interest., (Copyright © 2020 the Author(s). Published by PNAS.)
- Published
- 2020
- Full Text
- View/download PDF
114. A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue Vaccine.
- Author
-
Choy MM, Ng DHL, Siriphanitchakorn T, Ng WC, Sundstrom KB, Tan HC, Zhang SL, Chan KWK, Manuel M, Kini RM, Chan KR, Vasudevan SG, and Ooi EE
- Subjects
- Aedes virology, Animals, Chlorocebus aethiops, Dengue virology, Dengue Vaccines immunology, Endoplasmic Reticulum Stress, Female, Glycosylation, HEK293 Cells, Humans, Membrane Proteins metabolism, Mutagenesis, Site-Directed, Mutation, Vero Cells, Viral Nonstructural Proteins metabolism, Dengue Vaccines pharmacology, Dengue Virus genetics, Dengue Virus immunology, Viral Nonstructural Proteins genetics, Viral Nonstructural Proteins immunology
- Abstract
The molecular basis of dengue virus (DENV) attenuation remains ambiguous and hampers a targeted approach to derive safe but nonetheless immunogenic live vaccine candidates. Here, we take advantage of DENV serotype 2 PDK53 vaccine strain, which recently and successfully completed a phase-3 clinical trial, to identify how this virus is attenuated compared to its wild-type parent, DENV2 16681. Site-directed mutagenesis on a 16681 infectious clone identifies a single G53D substitution in the non-structural 1 (NS1) protein that reduces 16681 infection and dissemination in both Aedes aegypti, as well as in mammalian cells to produce the characteristic phenotypes of PDK53. Mechanistically, NS1 G53D impairs the function of a known host factor, the endoplasmic reticulum (ER)-resident ribophorin 1 protein, to properly glycosylate NS1 and thus induce a host antiviral gene through ER stress responses. Our findings provide molecular insights on DENV attenuation on a clinically tested strain., Competing Interests: Declaration of Interests E.E.O. served as a dengue vaccine advisory board member for Takeda Vaccines, which uses DENV2 PDK53 strain as a component of their dengue vaccine candidate, TAK-003., (Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
115. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development.
- Author
-
de Alwis R, Chen S, Gan ES, and Ooi EE
- Subjects
- Animals, Antibodies, Viral immunology, COVID-19, COVID-19 Vaccines, Clinical Trials, Phase I as Topic, Convalescence, Coronavirus Infections epidemiology, Coronavirus Infections prevention & control, Coronavirus Infections therapy, Dendritic Cells virology, Global Health, Host Microbial Interactions immunology, Humans, Immunization, Passive, Macrophages virology, Models, Animal, Monocytes virology, Plasma, Plasmapheresis, Pneumonia, Viral epidemiology, Pneumonia, Viral prevention & control, Pneumonia, Viral therapy, Receptors, Fc immunology, Translational Research, Biomedical, COVID-19 Serotherapy, Antibodies, Viral adverse effects, Coronavirus Infections immunology, Pandemics prevention & control, Pneumonia, Viral immunology, Viral Vaccines immunology, Virus Internalization
- Abstract
The pandemic spread of a novel coronavirus - SARS coronavirus-2 (SARS-CoV-2) as a cause of acute respiratory illness, named Covid-19, is placing the healthcare systems of many countries under unprecedented stress. Global economies are also spiraling towards a recession in fear of this new life-threatening disease. Vaccines that prevent SARS-CoV-2 infection and therapeutics that reduces the risk of severe Covid-19 are thus urgently needed. A rapid method to derive antiviral treatment for Covid-19 is the use of convalescent plasma derived hyperimmune globulin. However, both hyperimmune globulin and vaccine development face a common hurdle - the risk of antibody-mediated disease enhancement. The goal of this review is to examine the body of evidence supporting the hypothesis of immune enhancement that could be pertinent to Covid-19. We also discuss how this risk could be mitigated so that both hyperimmune globulin and vaccines could be rapidly translated to overcome the current global health crisis., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
116. When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?
- Author
-
Guy B, Ooi EE, Ramos-Castañeda J, and Thomas SJ
- Abstract
Recommendations have been issued for vaccinating with the Sanofi Pasteur tetravalent dengue vaccine (CYD-TDV, Dengvaxia
® ) individuals aged from 9 to 45/60 years old with a prior dengue virus (DENV) infection and living in endemic countries/areas. One question linked to these recommendations is to determine when it is possible to start vaccination after laboratory confirmed wild-type DENV infection, and this question can be relevant to any live vaccine to be used in endemic areas. To address it, we reviewed and discussed the immunological and practical considerations of live vaccination in this context. Firstly, the nature and kinetics of immune responses triggered by primary or secondary DENV infection may positively or negatively impact subsequent live vaccine take and associated clinical benefit, depending on when vaccination is performed after infection. Secondly, regarding practical aspects, the "easiest" situation would correspond to a confirmed acute dengue fever, only requiring knowing when the patient should come back for vaccination. However, in most cases, it will not be possible to firmly establish the actual date of infection and vaccination may have to take place during well-defined periods, regardless of when prior infection occurred. Evidence that informs health authorities and medical practitioners in formulating vaccine policies and implementing vaccine programs is thus needed. The present work reviewed the different elements of the guidance and proposes some key conclusions and recommendations.- Published
- 2020
- Full Text
- View/download PDF
117. Genetic diversity of respiratory enteroviruses and rhinoviruses in febrile adults, Singapore, 2007-2013.
- Author
-
Linster M, Donato C, Mah MG, Grau ML, Low JG, Ooi EE, Su YCF, Smith GJD, and Vijaykrishna D
- Subjects
- Adolescent, Adult, Aged, Enterovirus classification, Enterovirus isolation & purification, Enterovirus Infections epidemiology, Female, Humans, Male, Middle Aged, Phylogeny, Picornaviridae Infections epidemiology, Retrospective Studies, Rhinovirus classification, Rhinovirus isolation & purification, Seasons, Singapore epidemiology, Young Adult, Enterovirus genetics, Enterovirus Infections virology, Fever virology, Genetic Variation, Picornaviridae Infections virology, Rhinovirus genetics
- Abstract
To understand the genetic diversity and patterns of circulation of rhinoviruses (RV) and enteroviruses (EV) in Singapore, we retrospectively screened 2950 nasal swab samples collected from adults presenting to primary care services with signs of febrile illness in Singapore during 2007-2013 using sequencing and phylogenetic methods. Through sequencing and phylogenetic analysis, our results show the year-round circulation of the three rhinovirus species, A, B, and C. A diverse set of RV/EV serotypes were detected in Singapore with a predominance of RV-A in all years, whereas serotypes EV-C A21 and EV-D68 were only sporadically detected. This study highlights the previously unrecognized diversity and burden in the adult population in Singapore., (© 2019 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
118. Dengue pre-vaccination serology screening for the use of Dengvaxia®.
- Author
-
Hunsperger E, Peeling R, Gubler DJ, and Ooi EE
- Subjects
- Antibodies, Viral blood, Dengue immunology, Dengue Virus immunology, Humans, Predictive Value of Tests, Seroepidemiologic Studies, Vaccination, Dengue diagnosis, Dengue prevention & control, Dengue Vaccines administration & dosage, Serologic Tests, Travel
- Published
- 2019
- Full Text
- View/download PDF
119. Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance.
- Author
-
Ng KH, Zhang SL, Tan HC, Kwek SS, Sessions OM, Chan CY, Liu ID, Lee CK, Tambyah PA, Ooi EE, and Yap HK
- Subjects
- Aedes, Animals, Antibodies, Neutralizing immunology, Antibodies, Viral immunology, Cell Line, Cricetinae, Dengue complications, Female, Humans, Immunity, Cellular immunology, Immunity, Humoral immunology, Immunocompromised Host immunology, Kidney Transplantation, Lupus Erythematosus, Systemic complications, Lymphocyte Count, Lymphopenia complications, Lymphopenia immunology, RNA, Viral blood, Young Adult, Antibodies, Neutralizing blood, Antibodies, Viral blood, CD8-Positive T-Lymphocytes immunology, Dengue immunology, Dengue Virus immunology
- Abstract
Detailed understanding of the roles of humoral and cellular immune responses in sterilizing dengue virus (DENV) infection in humans is required to inform effective vaccine development. We report an unusual case of persistent DENV infection in a lymphopenic renal transplant recipient who was therapeutically immunosuppressed to prevent organ rejection. Following resolution of symptomatic dengue, this patient remained positive for DENV3 RNA in the blood for 4 months and viruric up to 9 months post-infection despite demonstrable levels of serum neutralizing antibodies throughout this period. Full resolution of DENV infection instead coincided with recovery of CD8+ T cell counts during reversal from lymphopenia. Taken collectively, our observations suggest a role for cellular immunity in sterilizing DENV infection in humans. Any dengue vaccine should thus be able to induce both humoral and cellular immunity that respectively prevent symptomatic infection and enable effective viral clearance., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
120. Erratum: Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.
- Author
-
Bidet K, Ho V, Chu CW, Naim ANM, Thazin K, Chan KR, Low JGH, Choy MM, Wong LH, de Sessions PF, Lee YH, Hibberd ML, Ooi EE, Fink K, and Chen J
- Abstract
[This corrects the article DOI: 10.1038/s41541-019-0119-3.]., (© The Author(s) 2019.)
- Published
- 2019
- Full Text
- View/download PDF
121. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
- Author
-
Chan CYY, Low JZH, Gan ES, Ong EZ, Zhang SL, Tan HC, Chai X, Ghosh S, Ooi EE, and Chan KR
- Subjects
- Antibody-Dependent Enhancement, Antigens, Viral immunology, Cell Line, Cells, Cultured, Dengue virology, Humans, Monocytes immunology, Monocytes virology, Sequence Analysis, RNA, Transcriptome, Virus Replication, Antibodies, Viral immunology, Dengue Virus physiology, Host Microbial Interactions, Receptors, IgG immunology, Virus Internalization
- Abstract
Dengue is caused by infection with any one of four dengue viruses (DENV); the risk of severe disease appears to be enhanced by the cross-reactive or subneutralizing levels of antibody from a prior DENV infection. These antibodies opsonize DENV entry through the activating Fc gamma receptors (FcγR), instead of infection through canonical receptor-mediated endocytosis, to result in higher levels of DENV replication. However, whether the enhanced replication is solely due to more efficient FcγR-mediated DENV entry or is also through FcγR-mediated alteration of the host transcriptome response to favor DENV infection remains unclear. Indeed, more efficient viral entry through activation of the FcγR can result in an increased viral antigenic load within target cells and confound direct comparisons of the host transcriptome response under antibody-dependent and antibody-independent conditions. Herein, we show that, despite controlling for the viral antigenic load in primary monocytes, the antibody-dependent and non-antibody-dependent routes of DENV entry induce transcriptome responses that are remarkably different. Notably, antibody-dependent DENV entry upregulated DENV host dependency factors associated with RNA splicing, mitochondrial respiratory chain complexes, and vesicle trafficking. Additionally, supporting findings from other studies, antibody-dependent DENV entry impeded the downregulation of ribosomal genes caused by canonical receptor-mediated endocytosis to increase viral translation. Collectively, our findings support the notion that antibody-dependent DENV entry alters host responses that support the viral life cycle and that host responses to DENV need to be defined in the context of its entry pathway. IMPORTANCE Dengue virus is the most prevalent mosquito-borne viral infection globally, resulting in variable manifestations ranging from asymptomatic viremia to life-threatening shock and multiorgan failure. Previous studies have indicated that the risk of severe dengue in humans can be increased by a specific range of preexisting anti-dengue virus antibody titers, a phenomenon termed antibody-dependent enhancement. There is hence a need to understand how antibodies augment dengue virus infection compared to the alternative canonical receptor-mediated viral entry route. Herein, we show that, besides facilitating viral uptake, antibody-mediated entry increases the expression of early host dependency factors to promote viral infection; these factors include RNA splicing, mitochondrial respiratory chain complexes, vesicle trafficking, and ribosomal genes. These findings will enhance our understanding of how differences in entry pathways can affect host responses and offer opportunities to design therapeutics that can specifically inhibit antibody-dependent enhancement of dengue virus infection., (Copyright © 2019 Chan et al.)
- Published
- 2019
- Full Text
- View/download PDF
122. Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live-attenuated yellow fever infection.
- Author
-
Chan KR, Gan ES, Chan CYY, Liang C, Low JZH, Zhang SL, Ong EZ, Bhatta A, Wijaya L, Lee YH, Low JG, and Ooi EE
- Subjects
- Adult, Citric Acid Cycle, Disease Susceptibility, Humans, Middle Aged, Reactive Oxygen Species metabolism, Vaccines, Attenuated immunology, Yellow Fever etiology, Endoplasmic Reticulum Stress, Yellow Fever metabolism, Yellow Fever Vaccine immunology
- Abstract
Flaviviral infections result in a wide spectrum of clinical outcomes, ranging from asymptomatic infection to severe disease. Although the correlates of severe disease have been explored
1-4 , the pathophysiology that differentiates symptomatic from asymptomatic infection remains undefined. To understand the molecular underpinnings of symptomatic infection, the blood transcriptomic and metabolomic profiles of individuals were examined before and after inoculation with the live yellow fever viral vaccine (YF17D). It was found that individuals with adaptive endoplasmic reticulum (ER) stress and reduced tricarboxylic acid cycle activity at baseline showed increased susceptibility to symptomatic outcome. YF17D infection in these individuals induced maladaptive ER stress, triggering downstream proinflammatory responses that correlated with symptomatic outcome. The findings of the present study thus suggest that the ER stress response and immunometabolism underpin symptomatic yellow fever and possibly even other flaviviral infections. Modulating either ER stress or metabolism could be exploited for prophylaxis against symptomatic flaviviral infection outcome.- Published
- 2019
- Full Text
- View/download PDF
123. Evolution of Subgenomic RNA Shapes Dengue Virus Adaptation and Epidemiological Fitness.
- Author
-
Finol E and Ooi EE
- Abstract
Changes in dengue virus (DENV) genome affect viral fitness both clinically and epidemiologically. Even in the 3' untranslated region (3' UTR), mutations could affect subgenomic flaviviral RNA (sfRNA) production and its affinity for host proteins, which are necessary for successful viral replication. Indeed, we recently showed that mutations in DENV2 3' UTR of epidemic strains increased sfRNA ability to bind host proteins and reduce interferon expression. However, whether 3' UTR differences shape the overall DENV evolution remains incompletely understood. Herein, we combined RNA phylogeny with phylogenetics to gain insights on sfRNA evolution. We found that sfRNA structures are under purifying selection and highly conserved despite sequence divergence. Only the second flaviviral nuclease-resistant RNA (fNR2) structure of DENV2 sfRNA has undergone strong positive selection. Epidemiological reports suggest that substitutions in fNR2 may drive DENV2 epidemiological fitness, possibly through sfRNA-protein interactions. Collectively, our findings indicate that 3' UTRs are important determinants of DENV fitness in human-mosquito cycles., (Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
124. A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in mice.
- Author
-
Chan KWK, Watanabe S, Jin JY, Pompon J, Teng D, Alonso S, Vijaykrishna D, Halstead SB, Marzinek JK, Bond PJ, Burla B, Torta F, Wenk MR, Ooi EE, and Vasudevan SG
- Subjects
- Amino Acid Sequence, Animals, Cell Line, Conserved Sequence, Culicidae virology, Gene Expression Regulation, Inflammation genetics, Kinetics, Leukocytes, Mononuclear virology, Mice, Models, Molecular, Mutant Proteins chemistry, Phylogeny, Protein Multimerization, Protein Stability, Viral Nonstructural Proteins chemistry, Virus Replication, Dengue pathology, Dengue virology, Dengue Virus genetics, Mutation genetics, Severity of Illness Index, Viral Nonstructural Proteins genetics
- Abstract
Dengue viruses cause severe and sudden human epidemics worldwide. The secreted form of the nonstructural protein 1 (sNS1) of dengue virus causes vascular leakage, a hallmark of severe dengue disease. Here, we reverse engineered the T164S mutation of NS1, associated with the severity of dengue epidemics in the Americas, into a dengue virus serotype 2 mildly infectious strain. The T164S mutant virus decreased infectious virus production and increased sNS1 production in mammalian cell lines and human peripheral blood mononuclear cells (PBMCs) without affecting viral RNA replication. Gene expression profiling of 268 inflammation-associated human genes revealed up-regulation of genes induced in response to vascular leakage. Infection of the mosquito vector Aedes aegypti with the T164S mutant virus resulted in increased viral load in the mosquito midgut and higher sNS1 production compared to wild-type virus infection. Infection of type 1 and 2 interferon receptor-deficient AG129 mice with the T164S mutant virus resulted in severe disease coupled with increased complement activation, tissue inflammation, and more rapid mortality compared to AG129 mice infected with wild-type virus. Molecular dynamics simulations predicted that mutant sNS1 formed stable dimers similar to the wild-type protein, whereas the hexameric mutant sNS1 was predicted to be unstable. Immunoaffinity-purified sNS1 from T164S mutant virus-infected mammalian cells was associated with different lipid classes compared to wild-type sNS1. Treatment of human PBMCs with sNS1 purified from T164S mutant virus resulted in a twofold higher production of proinflammatory cytokines, suggesting a mechanism for how mutant sNS1 may cause more severe dengue disease., (Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
- Published
- 2019
- Full Text
- View/download PDF
125. Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.
- Author
-
Bidet K, Ho V, Chu CW, Naim ANH, Thazin K, Chan KR, Low JGH, Choy MM, Wong LH, Florez de Sessions P, Lee YH, Hibberd ML, Ooi EE, Fink K, and Chen J
- Abstract
Neutralizing antibodies (nAbs) are a critical component for protection against dengue virus (DENV) infection, but little is known about the immune mechanisms governing their induction and whether such mechanisms can be harnessed for vaccine development. In this study, we profiled the early immune responses to flaviviruses in human peripheral blood mononuclear cells and screened a panel of toll-like receptor (TLR) agonists that stimulate the same immune signatures. Monocyte/macrophage-driven inflammatory responses and interferon responses were characteristics of flavivirus infection and associated with induction of nAbs in humans immunized with the yellow fever vaccine YF-17D. The signatures were best reproduced by the combination of TLR agonists Pam
3 CSK4 and PolyI:C (PP). Immunization of both mice and macaques with a poorly immunogenic recombinant DENV-2 envelope domain III (EDIII) induced more consistent nAb and CD4+ T-cell responses with PP compared to alum plus monophosphoryl lipid A. Induction of nAbs by PP required interferon-mediated signals in macrophages in mice. However, EDIII + PP vaccination only provided partial protection against viral challenge. These results provide insights into mechanisms underlying nAb induction and a basis for further improving antigen/adjuvant combinations for dengue vaccine development., Competing Interests: Competing interestsThe authors declare no competing interests.- Published
- 2019
- Full Text
- View/download PDF
126. Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice.
- Author
-
Hou J, Shrivastava S, Fraser CC, Loo HL, Wong LH, Ho V, Fink K, Ooi EE, and Chen J
- Subjects
- Animals, Female, Mice, Serogroup, Vaccines, Synthetic genetics, Vaccines, Synthetic immunology, Antibodies, Neutralizing immunology, Antibodies, Viral immunology, Dengue genetics, Dengue immunology, Dengue prevention & control, Dengue Vaccines genetics, Dengue Vaccines immunology, Dengue Virus genetics, Dengue Virus immunology, Epitopes, T-Lymphocyte genetics, Epitopes, T-Lymphocyte immunology
- Abstract
An estimated 400 million people in the world are infected with any of the four types of dengue virus (DENV) annually. The only licensed dengue vaccine cannot effectively prevent infection with all of the four DENVs, especially in those immunologically naïve at baseline. In this study, we explored a mosaic vaccine approach, which utilizes an artificial recombinant sequence for each serotype to achieve maximum coverage of variant epitopes in the four DENVs. We determined the immunogenicity and cross-reactivity of DNA plasmids encoding individual mosaic sequences or the natural sequences in mice. We show that the mosaic vaccines, particularly those targeting DENV serotype 1 and 2, improved vaccine immunogenicity by increasing the percentage of antigen-specific IFNγ- or TNFα-secreting CD4 and CD8 T cells, and titers of neutralizing antibodies. The mosaic vaccine diversified and broadened anti-dengue T cell responses and cross-reactive neutralizing antibodies against all four serotypes. The mosaic vaccines also induced higher level of antigen-specific B cell responses. These results suggest that mosaic vaccines comprising of DENV serotype 1 and 2 variant epitopes could stimulate strong and broad immune responses against all four serotypes.
- Published
- 2019
- Full Text
- View/download PDF
127. Genomic signature of early T-cell response is associated with lower antibody titer threshold for sterilizing immunity.
- Author
-
Ong EZ, Gan ES, de Alwis R, Wijaya L, Ong XM, Zhang M, Wong AW, Cheung YB, Zellweger RM, Ooi EE, and Low JG
- Subjects
- Female, Gene Expression Profiling, Humans, Immunity, Herd genetics, Immunity, Herd physiology, Male, Antibodies, Viral analysis, Antibodies, Viral blood, Antibodies, Viral genetics, Measles-Mumps-Rubella Vaccine immunology, T-Lymphocytes immunology
- Abstract
Vaccination is an effective approach to reduce disease burden. High vaccination coverage blocks pathogen transmission to ensure herd immunity. However, the concept of herd immunity assumes that vaccinated individuals cannot be infected and mediate silent pathogen transmission. While the correlates of vaccine-mediated protection against disease have been examined, the correlates of sterilizing immunity that prevents infection have not been systematically defined. Here, we used full genome expression profiling to explore the molecular correlates of serological response and non-response to measles, mumps and rubella (MMR) vaccination as surrogates of infection and sterilizing immunity, respectively. We observed that the antibody titers needed to sterilize infection with the vaccine strains were higher than current WHO disease protection thresholds. In subjects with baseline antibodies below such sterilizing immunity thresholds, serological non-response to MMR vaccination was associated with gene expression profile indicative of early T-cell activation and signalling. Specifically, genes that regulate T-cell function and response were induced at day 1 post-vaccination in non-responders but not in responders. These findings suggest that rapid T-cell response prevented MMR vaccine infection to limit antigenic presentation and hence serological response. Collectively, our findings suggest an important role for T-cells in engendering sterilizing immunity., (Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
128. Application of a targeted-enrichment methodology for full-genome sequencing of Dengue 1-4, Chikungunya and Zika viruses directly from patient samples.
- Author
-
Kamaraj US, Tan JH, Xin Mei O, Pan L, Chawla T, Uehara A, Wang LF, Ooi EE, Gubler DJ, Tissera H, Ng LC, Wilder-Smith A, de Sessions PF, Barkham T, Anderson DE, and Sessions OM
- Subjects
- Cell Line, Chikungunya Fever diagnosis, Chikungunya virus isolation & purification, Coinfection epidemiology, Coinfection transmission, Computational Biology, Dengue diagnosis, Dengue Virus isolation & purification, Disease Outbreaks, Genomics, High-Throughput Nucleotide Sequencing, Humans, Singapore epidemiology, Sri Lanka epidemiology, Zika Virus isolation & purification, Zika Virus Infection diagnosis, Chikungunya virus genetics, Dengue Virus genetics, Genome, Viral, Nucleic Acid Amplification Techniques methods, Zika Virus genetics
- Abstract
The frequency of epidemics caused by Dengue viruses 1-4, Zika virus and Chikungunya viruses have been on an upward trend in recent years driven primarily by uncontrolled urbanization, mobility of human populations and geographical spread of their shared vectors, Aedes aegypti and Aedes albopictus. Infections by these viruses present with similar clinical manifestations making them challenging to diagnose; this is especially difficult in regions of the world hyperendemic for these viruses. In this study, we present a targeted-enrichment methodology to simultaneously sequence the complete viral genomes for each of these viruses directly from clinical samples. Additionally, we have also developed a customized computational tool (BaitMaker) to design these enrichment baits. This methodology is robust in its ability to capture diverse sequences and is amenable to large-scale epidemiological studies. We have applied this methodology to two large cohorts: a febrile study based in Colombo, Sri Lanka taken during the 2009-2015 dengue epidemic (n = 170) and another taken during the 2016 outbreak of Zika virus in Singapore (n = 162). Results from these studies indicate that we were able to cover an average of 97.04% ± 0.67% of the full viral genome from samples in these cohorts. We also show detection of one DENV3/ZIKV co-infected patient where we recovered full genomes for both viruses., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
129. Structure mapping of dengue and Zika viruses reveals functional long-range interactions.
- Author
-
Huber RG, Lim XN, Ng WC, Sim AYL, Poh HX, Shen Y, Lim SY, Sundstrom KB, Sun X, Aw JG, Too HK, Boey PH, Wilm A, Chawla T, Choy MM, Jiang L, de Sessions PF, Loh XJ, Alonso S, Hibberd M, Nagarajan N, Ooi EE, Bond PJ, Sessions OM, and Wan Y
- Subjects
- Animals, Base Sequence, Cell Line, Conserved Sequence, Genome, Viral, Humans, Mice, Models, Molecular, Mutation genetics, Nicotinic Acids, RNA, Viral chemistry, Virion genetics, Chromosome Mapping, Dengue Virus chemistry, Dengue Virus genetics, Zika Virus chemistry, Zika Virus genetics
- Abstract
Dengue (DENV) and Zika (ZIKV) viruses are clinically important members of the Flaviviridae family with an 11 kb positive strand RNA genome that folds to enable virus function. Here, we perform structure and interaction mapping on four DENV and ZIKV strains inside virions and in infected cells. Comparative analysis of SHAPE reactivities across serotypes nominates potentially functional regions that are highly structured, conserved, and contain low synonymous mutation rates. Interaction mapping by SPLASH identifies many pair-wise interactions, 40% of which form alternative structures, suggesting extensive structural heterogeneity. Analysis of shared interactions between serotypes reveals a conserved macro-organization whereby interactions can be preserved at physical locations beyond sequence identities. We further observe that longer-range interactions are preferentially disrupted inside cells, and show the importance of new interactions in virus fitness. These findings deepen our understanding of Flavivirus genome organization and serve as a resource for designing therapeutics in targeting RNA viruses.
- Published
- 2019
- Full Text
- View/download PDF
130. Microneedle-based intradermal delivery of stabilized dengue virus.
- Author
-
Turvey ME, Uppu DSSM, Mohamed Sharif AR, Bidet K, Alonso S, Ooi EE, and Hammond PT
- Abstract
Current live-attenuated dengue vaccines require strict cold chain storage. Methods to preserve dengue virus (DENV) viability, which enable vaccines to be transported and administered at ambient temperatures, will be decisive towards the implementation of affordable global vaccination schemes with broad immunization coverage in resource-limited areas. We have developed a microneedle (MN)-based vaccine platform for the stabilization and intradermal delivery of live DENV from minimally invasive skin patches. Dengue virus-stabilized microneedle arrays (VSMN) were fabricated using saccharide-based formulation of virus and could be stored dry at ambient temperature up to 3 weeks with maintained virus viability. Following intradermal vaccination, VSMN-delivered DENV was shown to elicit strong neutralizing antibody responses and protection from viral challenge, comparable to that of the conventional liquid vaccine administered subcutaneously. This work supports the potential for MN-based dengue vaccine technology and the progression towards cold chain-independence. Dengue virus can be stabilized using saccharide-based formulations and coated on microneedle array vaccine patches for storage in dry state with preserved viability at ambient temperature (VSMN; virus-stabilized microneedle arrays)., Competing Interests: The authors have no conflicts of interest to declare.
- Published
- 2019
- Full Text
- View/download PDF
131. Dengue.
- Author
-
Wilder-Smith A, Ooi EE, Horstick O, and Wills B
- Subjects
- Animals, Arthropod Vectors, Drug Discovery, Global Health, Humans, Serogroup, Vaccination methods, Dengue epidemiology, Dengue Vaccines, Dengue Virus pathogenicity, Nucleic Acid Amplification Techniques methods
- Abstract
Mortality from severe dengue is low, but the economic and resource burden on health services remains substantial in endemic settings. Unfortunately, progress towards development of effective therapeutics has been slow, despite notable advances in the understanding of disease pathogenesis and considerable investment in antiviral drug discovery. For decades antibody-dependent enhancement has been the prevalent model to explain dengue pathogenesis, but it was only recently demonstrated in vivo and in clinical studies. At present, the current mainstay of management for most symptomatic dengue patients remains careful observation and prompt but judicious use of intravenous hydration therapy for those with substantial vascular leakage. Various new promising technologies for diagnosis of dengue are currently in the pipeline. New sample-in, answer-out nucleic acid amplification technologies for point-of-care use are being developed to improve performance over current technologies, with the potential to test for multiple pathogens using a single specimen. The search for biomarkers that reliably predict development of severe dengue among symptomatic individuals is also a major focus of current research efforts. The first dengue vaccine was licensed in 2015 but its performance depends on serostatus. There is an urgent need to identify correlates of both vaccine protection and disease enhancement. A crucial assessment of vector control tools should guide a research agenda for determining the most effective interventions, and how to best combine state-of-the-art vector control with vaccination., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
132. Cell surface α2,3-linked sialic acid facilitates Zika virus internalization.
- Author
-
Tan CW, Huan Hor CH, Kwek SS, Tee HK, Sam IC, Goh ELK, Ooi EE, Chan YF, and Wang LF
- Subjects
- Animals, Cell Line, Humans, N-Acetylneuraminic Acid metabolism, Receptors, Virus metabolism, Virus Internalization, Zika Virus physiology
- Abstract
The emergence of neurotropic Zika virus (ZIKV) raised a public health emergency of global concern. ZIKV can cross the placental barrier and infect foetal brains, resulting in microcephaly, but the pathogenesis of ZIKV is poorly understood. With recent findings reporting AXL as a type I interferon antagonist rather than an entry receptor, the exact entry mechanism remains unresolved. Here we report that cell surface sialic acid plays an important role in ZIKV infection. Removal of cell surface sialic acid by neuraminidase significantly abolished ZIKV infection in Vero cells and human induced-pluripotent stem cells-derived neural progenitor cells. Furthermore, knockout of the sialic acid biosynthesis gene encoding UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase resulted in significantly less ZIKV infection of both African and Asian lineages. Huh7 cells deficient in α2,3-linked sialic acid through knockout of ST3 β-galactoside-α2,3-sialyltransferase 4 had significantly reduced ZIKV infection. Removal of membrane-bound, un-internalized virus with pronase treatment revealed the role of sialic acid in ZIKV internalization but not attachment. Sialyllactose inhibition studies showed that there is no direct interaction between sialic acid and ZIKV, implying that sialic acid could be mediating ZIKV-receptor complex internalization. Identification of α2,3-linked sialic acid as an important host factor for ZIKV internalization provides new insight into ZIKV infection and pathogenesis.
- Published
- 2019
- Full Text
- View/download PDF
133. Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine.
- Author
-
Skibinski DAG, Jones LA, Zhu YO, Xue LW, Au B, Lee B, Naim ANM, Lee A, Kaliaperumal N, Low JGH, Lee LS, Poidinger M, Saudan P, Bachmann M, Ooi EE, Hanson BJ, Novotny-Diermayr V, Matter A, Fairhurst AM, Hibberd ML, and Connolly JE
- Subjects
- Adult, Antibody Formation, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Cell Proliferation, Cohort Studies, Female, Humans, Immunity, Cellular immunology, Influenza, Human immunology, Influenza, Human metabolism, Male, Middle Aged, Vaccination, Young Adult, CD4-Positive T-Lymphocytes physiology, CD8-Positive T-Lymphocytes physiology, Cytokines metabolism, Influenza Vaccines immunology, Influenza, Human prevention & control, Lymphocyte Activation immunology
- Abstract
Cell mediated immunity plays a vital role in defense against influenza infection in humans. Less is known about the role of vaccine-induced cell mediated immunity and the cytokine responses elicited. We measured CD4
+ and CD8+ T-cell reactivity in human subjects following vaccination with licensed trivalent influenza vaccine and a novel virus-like particle based vaccine. We detected influenza-specific CD4+ T-cell responses following vaccination with the licensed trivalent influenza vaccine and found that these correlated with antibody measurements. Administration of the novel virus-like particle based vaccine elicited influenza-specific CD4+ and CD8+ T-cell responses and the induction of the cytokines IFN-γ, IL-17A, IL17F, IL-5, IL-13, IL-9, IL-10 and IL-21. Pre-existing cytokine responses influenced the profile of the cytokine response elicited by vaccination. In a subset of individuals the VLP vaccine changed pre-vaccination production of type 2 cytokines such as IL-5 and IL-13 to a post-vaccination type 1 cytokine signature characterized by IFN-γ. A transcriptional signature to vaccination was found to correlate with antibody titer, IFN-γ production by T-cells and expression of a putative RNA helicase, DDX17, on the surface of immune cells.- Published
- 2018
- Full Text
- View/download PDF
134. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway.
- Author
-
Ye W, Chew M, Hou J, Lai F, Leopold SJ, Loo HL, Ghose A, Dutta AK, Chen Q, Ooi EE, White NJ, Dondorp AM, Preiser P, and Chen J
- Subjects
- CRISPR-Cas Systems, Cells, Cultured, Cytoplasm metabolism, Erythrocytes metabolism, Erythrocytes parasitology, Humans, Interferon-Induced Helicase, IFIH1 antagonists & inhibitors, Interferon-Induced Helicase, IFIH1 genetics, Killer Cells, Natural metabolism, Killer Cells, Natural parasitology, Lymphocyte Activation, Malaria, Falciparum metabolism, Malaria, Falciparum parasitology, Plasmodium falciparum isolation & purification, Cell-Derived Microparticles immunology, Erythrocytes immunology, Interferon-Induced Helicase, IFIH1 metabolism, Killer Cells, Natural immunology, Malaria, Falciparum immunology, Plasmodium falciparum immunology
- Abstract
Natural killer (NK) cells provide the first line of defense against malaria parasite infection. However, the molecular mechanisms through which NK cells are activated by parasites are largely unknown, so is the molecular basis underlying the variation in NK cell responses to malaria infection in the human population. Here, we compared transcriptional profiles of responding and non-responding NK cells following exposure to Plasmodium-infected red blood cells (iRBCs) and identified MDA5, a RIG-I-like receptor involved in sensing cytosolic RNAs, to be differentially expressed. Knockout of MDA5 in responding human NK cells by CRISPR/cas9 abolished NK cell activation, IFN-γ secretion, lysis of iRBCs. Similarly, inhibition of TBK1/IKKε, an effector molecule downstream of MDA5, also inhibited activation of responding NK cells. Conversely, activation of MDA5 by liposome-packaged poly I:C restored non-responding NK cells to lyse iRBCs. We further show that microvesicles containing large parasite RNAs from iRBCs activated NK cells by fusing with NK cells. These findings suggest that NK cells are activated through the MDA5 pathway by parasite RNAs that are delivered to the cytoplasm of NK cells by microvesicles from iRBCs. The difference in MDA5 expression between responding and non-responding NK cells following exposure to iRBCs likely contributes to the variation in NK cell responses to malaria infection in the human population., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
135. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
- Author
-
Lim MQ, Kumaran EAP, Tan HC, Lye DC, Leo YS, Ooi EE, MacAry PA, Bertoletti A, and Rivino L
- Subjects
- Cells, Cultured, Cross Reactions immunology, Cytokines immunology, Dengue blood, Epitopes, T-Lymphocyte immunology, Humans, Immunity, Heterologous immunology, RNA Helicases immunology, Serine Endopeptidases immunology, Zika Virus Infection, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Capsid immunology, Dengue Virus immunology, Immunologic Memory, Viral Nonstructural Proteins immunology, Zika Virus immunology
- Abstract
Zika virus (ZIKV), a flavivirus with homology to dengue virus (DENV), is spreading to areas of DENV hyper-endemicity. Heterologous T cell immunity, whereby virus-specific memory T cells are activated by variant peptides derived from a different virus, can lead to enhanced viral clearance or diminished protective immunity and altered immunopathology. In mice, CD8+ T cells specific for DENV provide in vivo protective efficacy against subsequent ZIKV infection. In humans, contrasting studies report complete absence or varying degrees of DENV/ZIKV T cell cross-reactivity. Moreover, the impact of cross-reactive T cell recognition on the anti-viral capacity of T cells remains unclear. Here, we show that DENV-specific memory T cells display robust cross-reactive recognition of ZIKV NS3 ex vivo and after in vitro expansion in respectively n = 7/10 and n = 9/9 dengue-immune individuals tested. In contrast, cross-reactivity toward ZIKV capsid is low or absent. Cross-reactive recognition of DENV or ZIKV NS3 peptides elicits similar production of the anti-viral effector mediators IFN-γ, TNF-α, and CD107a. We identify 9 DENV/ZIKV cross-reactive epitopes, 7 of which are CD4+ and 2 are CD8+ T cell epitopes. We also show that cross-reactive CD4+ and CD8+ T cells targeting novel NS3 epitopes display anti-viral effector potential toward ZIKV-infected cells, with CD8+ T cells mediating direct lyses of these cells. Our results demonstrate that DENV NS3-specific memory T cells display anti-viral effector capacity toward ZIKV, suggesting a potential beneficial effect in humans of pre-existing T cell immunity to DENV upon ZIKV infection.
- Published
- 2018
- Full Text
- View/download PDF
136. Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells.
- Author
-
Saron WAA, Rathore APS, Ting L, Ooi EE, Low J, Abraham SN, and St John AL
- Subjects
- Amino Acid Sequence, Animals, Antibodies, Neutralizing immunology, CD4-Positive T-Lymphocytes cytology, CD4-Positive T-Lymphocytes metabolism, Dengue Virus classification, Dengue Virus immunology, Encephalitis Virus, Japanese classification, Encephalitis Virus, Japanese immunology, Epitopes chemistry, Epitopes immunology, Flavivirus classification, Humans, Immunity, Cellular, Immunity, Humoral, Immunologic Memory, Leukocytes, Mononuclear cytology, Leukocytes, Mononuclear immunology, Leukocytes, Mononuclear metabolism, Mice, Mice, Inbred C57BL, Phylogeny, Yellow fever virus classification, Yellow fever virus immunology, CD4-Positive T-Lymphocytes immunology, Cross Reactions immunology, Flavivirus immunology
- Abstract
How previous immunity influences immune memory recall and protection against related flaviviruses is largely unknown, yet encounter with multiple flaviviruses in a lifetime is increasingly likely. Using sequential challenges with dengue virus (DENV), yellow fever virus (YFV), and Japanese encephalitis virus (JEV), we induced cross-reactive cellular and humoral immunity among flaviviruses from differing serocomplexes. Antibodies against JEV enhanced DENV replication; however, JEV immunity was protective in vivo during secondary DENV1 infection, promoting rapid gains in antibody avidity. Mechanistically, JEV immunity activated dendritic cells and effector memory T cells, which developed a T follicular helper cell phenotype in draining lymph nodes upon secondary DENV1 infection. We identified cross-reactive epitopes that promote recall from a pool of flavivirus serocomplex cross-reactive memory CD4 T cells and confirmed that a similar serocomplex cross-reactive immunity occurs in humans. These results show that sequential immunizations for flaviviruses sharing CD4 epitopes should promote protection during a subsequent heterologous infection.
- Published
- 2018
- Full Text
- View/download PDF
137. Identification and characterization of host proteins bound to dengue virus 3' UTR reveal an antiviral role for quaking proteins.
- Author
-
Liao KC, Chuo V, Ng WC, Neo SP, Pompon J, Gunaratne J, Ooi EE, and Garcia-Blanco MA
- Subjects
- Dengue genetics, Dengue virology, Genome, Viral, HEK293 Cells, Humans, RNA-Binding Proteins genetics, 3' Untranslated Regions, Antiviral Agents pharmacology, Dengue prevention & control, Dengue Virus drug effects, RNA, Viral genetics, RNA-Binding Proteins metabolism, Virus Replication drug effects
- Abstract
The four dengue viruses (DENV1-4) are rapidly reemerging infectious RNA viruses. These positive-strand viral genomes contain structured 3' untranslated regions (UTRs) that interact with various host RNA binding proteins (RBPs). These RBPs are functionally important in viral replication, pathogenesis, and defense against host immune mechanisms. Here, we combined RNA chromatography and quantitative mass spectrometry to identify proteins interacting with DENV1-4 3' UTRs. As expected, RBPs displayed distinct binding specificity. Among them, we focused on quaking (QKI) because of its preference for the DENV4 3' UTR (DENV-4/SG/06K2270DK1/2005). RNA immunoprecipitation experiments demonstrated that QKI interacted with DENV4 genomes in infected cells. Moreover, QKI depletion enhanced infectious particle production of DENV4. On the contrary, QKI did not interact with DENV2 3' UTR, and DENV2 replication was not affected consistently by QKI depletion. Next, we mapped the QKI interaction site and identified a QKI response element (QRE) in DENV4 3' UTR. Interestingly, removal of QRE from DENV4 3' UTR abolished this interaction and increased DENV4 viral particle production. Introduction of the QRE to DENV2 3' UTR led to QKI binding and reduced DENV2 infectious particle production. Finally, reporter assays suggest that QKI reduced translation efficiency of viral RNA. Our work describes a novel function of QKI in restricting viral replication., (© 2018 Liao et al.; Published by Cold Spring Harbor Laboratory Press for the RNA Society.)
- Published
- 2018
- Full Text
- View/download PDF
138. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
- Author
-
Tharakaraman K, Watanabe S, Chan KR, Huan J, Subramanian V, Chionh YH, Raguram A, Quinlan D, McBee M, Ong EZ, Gan ES, Tan HC, Tyagi A, Bhushan S, Lescar J, Vasudevan SG, Ooi EE, and Sasisekharan R
- Subjects
- Animals, Antibodies, Monoclonal administration & dosage, Antibodies, Monoclonal immunology, Antibodies, Monoclonal therapeutic use, Antibodies, Neutralizing administration & dosage, Antibodies, Neutralizing therapeutic use, Antibodies, Viral administration & dosage, Antibodies, Viral therapeutic use, Dengue Virus immunology, Disease Models, Animal, Epitopes chemistry, Epitopes genetics, Female, Male, Mice, Models, Molecular, Neutralization Tests methods, Pregnancy, Protein Structure, Quaternary, Treatment Outcome, Viral Envelope Proteins chemistry, Viral Envelope Proteins genetics, Viral Envelope Proteins immunology, Viremia drug therapy, Zika Virus Infection drug therapy, Zika Virus Infection virology, Antibodies, Neutralizing immunology, Antibodies, Viral chemistry, Antibodies, Viral immunology, Epitopes immunology, Protein Engineering, Zika Virus genetics, Zika Virus immunology, Zika Virus Infection immunology
- Abstract
Following the recent emergence of Zika virus (ZIKV), many murine and human neutralizing anti-ZIKV antibodies have been reported. Given the risk of virus escape mutants, engineering antibodies that target mutationally constrained epitopes with therapeutically relevant potencies can be valuable for combating future outbreaks. Here, we applied computational methods to engineer an antibody, ZAb_FLEP, that targets a highly networked and therefore mutationally constrained surface formed by the envelope protein dimer. ZAb_FLEP neutralized a breadth of ZIKV strains and protected mice in distinct in vivo models, including resolving vertical transmission and fetal mortality in infected pregnant mice. Serial passaging of ZIKV in the presence of ZAb_FLEP failed to generate viral escape mutants, suggesting that its epitope is indeed mutationally constrained. A single-particle cryo-EM reconstruction of the Fab-ZIKV complex validated the structural model and revealed insights into ZAb_FLEP's neutralization mechanism. ZAb_FLEP has potential as a therapeutic in future outbreaks., (Copyright © 2018. Published by Elsevier Inc.)
- Published
- 2018
- Full Text
- View/download PDF
139. A systematic approach to the development of a safe live attenuated Zika vaccine.
- Author
-
Kwek SS, Watanabe S, Chan KR, Ong EZ, Tan HC, Ng WC, Nguyen MTX, Gan ES, Zhang SL, Chan KWK, Tan JH, Sessions OM, Manuel M, Pompon J, Chua C, Hazirah S, Tryggvason K, Vasudevan SG, and Ooi EE
- Subjects
- Aedes immunology, Aedes virology, Animals, Dendritic Cells immunology, Dendritic Cells virology, Humans, Mice, Vaccines, Attenuated administration & dosage, Vaccines, Attenuated genetics, Viral Vaccines administration & dosage, Viral Vaccines genetics, Zika Virus growth & development, Zika Virus Infection immunology, Zika Virus Infection virology, Immunologic Techniques, Vaccines, Attenuated immunology, Viral Vaccines immunology, Zika Virus genetics, Zika Virus immunology, Zika Virus Infection prevention & control
- Abstract
Zika virus (ZIKV) is a flavivirus that can cause congenital disease and requires development of an effective long-term preventative strategy. A replicative ZIKV vaccine with properties similar to the yellow fever 17D (YF17D) live-attenuated vaccine (LAV) would be advantageous, as a single dose of YF17D produces lifelong immunity. However, a replicative ZIKV vaccine must also be safe from causing persistent organ infections. Here we report an approach to ZIKV LAV development. We identify a ZIKV variant that produces small plaques due to interferon (IFN)-restricted viral propagation and displays attenuated infection of endothelial cells. We show that these properties collectively reduce the risk of organ infections and vertical transmission in a mouse model but remain sufficiently immunogenic to prevent wild-type ZIKV infection. Our findings suggest a strategy for the development of a safe but efficacious ZIKV LAV.
- Published
- 2018
- Full Text
- View/download PDF
140. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
- Author
-
Budigi Y, Ong EZ, Robinson LN, Ong LC, Rowley KJ, Winnett A, Tan HC, Hobbie S, Shriver Z, Babcock GJ, Alonso S, and Ooi EE
- Subjects
- Animals, Antibodies, Neutralizing blood, Antibodies, Viral administration & dosage, Antibodies, Viral blood, Antibodies, Viral genetics, Antigens, Viral chemistry, Antigens, Viral genetics, Cell Line, Chlorocebus aethiops, Cross Reactions immunology, Dengue Virus genetics, Dengue Virus pathogenicity, Disease Models, Animal, Epitopes, Female, Humans, Immune Sera, Immunotherapy, In Vitro Techniques, Mice, Models, Structural, Mutation, Neutralization Tests, Protein Conformation, Recombinant Proteins chemistry, Recombinant Proteins genetics, Recombinant Proteins immunology, Serogroup, THP-1 Cells, Vero Cells, Viral Envelope Proteins chemistry, Viral Envelope Proteins genetics, Viral Plaque Assay, Antibodies, Monoclonal immunology, Antibodies, Neutralizing immunology, Antibodies, Viral immunology, Dengue immunology, Dengue Virus immunology, Viral Envelope Proteins immunology
- Abstract
Dengue virus (DENV) infection imposes enormous health and economic burden worldwide with no approved treatment. Several small molecules, including lovastatin, celgosivir, balapiravir and chloroquine have been tested for potential anti-dengue activity in clinical trials; none of these have demonstrated a protective effect. Recently, based on identification and characterization of cross-serotype neutralizing antibodies, there is increasing attention on the potential for dengue immunotherapy. Here, we tested the ability of VIS513, an engineered cross-neutralizing humanized antibody targeting the DENV E protein domain III, to overcome antibody-enhanced infection and high but brief viremia, which are commonly encountered in dengue patients, in various in vitro and in vivo models. We observed that VIS513 efficiently neutralizes DENV at clinically relevant viral loads or in the presence of enhancing levels of DENV immune sera. Single therapeutic administration of VIS513 in mouse models of primary infection or lethal secondary antibody-enhanced infection, reduces DENV titers and protects from lethal infection. Finally, VIS513 administration does not readily lead to resistance, either in cell culture systems or in animal models of dengue infection. The findings suggest that rapid viral reduction during acute DENV infection with a monoclonal antibody is feasible.
- Published
- 2018
- Full Text
- View/download PDF
141. Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection.
- Author
-
Cui L, Pang J, Lee YH, Ooi EE, Ong CN, Leo YS, and Tannenbaum SR
- Subjects
- Adult, Humans, Mass Spectrometry, Metabolome, Serum chemistry, Severe Dengue pathology
- Abstract
Dengue virus (DENV) is the most prevalent arbovirus leading to an estimated 100 million symptomatic dengue infections every year. DENV can cause a spectrum of clinical manifestations, ranging from mild dengue fever (DF) to more life threatening forms such as dengue hemorrhagic fever (DHF). The clinical symptoms of DHF become evident typically at the critical phase of infection (5-7 days after onset of fever), yet the mechanisms that trigger transition from DF to DHF are not well understood. We performed a mass spectrometry-based metabolomic profiling of sera from adult DF and DHF patients at the critical and recovery phases of infection. There were 29 differentially expressed metabolites identified between DF and DHF at the critical phase. These include bile acids, purines, acylcarnitines, phospholipids, and amino acids. Bile acids were observed up to 5 fold higher levels among DHF compared to DF patients and were significantly correlated to the higher levels of aspartate transaminase (AST) and alanine transaminase (ALT), suggestive of liver injury among DHF. Uric acid, the most abundant antioxidant in the blood, was observed to be 1.5 fold lower among DHF compared to DF patients. This could result in decreased capacity of endogenous antioxidant defense and elevated oxidative stress among DHF patients. In the recovery phase, the levels of eight metabolites were still significantly higher or lower among DHF patients, including chenodeoxyglycocholic acid, one of the bile acids observed at the critical phase. This indicates potential prolonged adverse impact on the liver due to DENV infection in DHF patients. Our study identified altered metabolic pathways linked to DHF in the critical and recovery phases of dengue infection and provided insights into the different host and DENV interactions between DF and DHF. The results advance our understanding on the mechanisms of DHF pathogenesis, alluding to possible novel therapeutic targets to dengue management.
- Published
- 2018
- Full Text
- View/download PDF
142. Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.
- Author
-
Lam JH, Chua YL, Lee PX, Martínez Gómez JM, Ooi EE, and Alonso S
- Subjects
- Animals, Antibodies, Neutralizing immunology, Antibodies, Viral biosynthesis, Antibodies, Viral immunology, Dengue immunology, Dengue Virus immunology, Female, Immunity, Cellular, Immunity, Maternally-Acquired, Male, Maternal-Fetal Exchange immunology, Mice, 129 Strain, Pregnancy, Seroconversion, CD8-Positive T-Lymphocytes immunology, Dengue prevention & control, Dengue Vaccines immunology
- Abstract
Declining levels of maternal antibodies were shown to sensitize infants born to dengue-immune mothers to severe disease during primary infection, through the process of antibody-dependent enhancement of infection (ADE). With the recent approval for human use of Sanofi-Pasteur's chimeric dengue vaccine CYD-TDV and several vaccine candidates in clinical development, the scenario of infants born to vaccinated mothers has become a reality. This raises 2 questions: will declining levels of maternal vaccine-induced antibodies cause ADE; and, will maternal antibodies interfere with vaccination efficacy in the infant? To address these questions, the above scenario was modeled in mice. Type I IFN-deficient female mice were immunized with live attenuated DENV2 PDK53, the core component of the tetravalent DENVax candidate currently under clinical development. Pups born to PDK53-immunized dams acquired maternal antibodies that strongly neutralized parental strain 16681, but not the heterologous DENV2 strain D2Y98P-PP1, and instead caused ADE during primary infection with this strain. Furthermore, pups failed to seroconvert after PDK53 vaccination, owing to maternal antibody interference. However, a cross-protective multifunctional CD8+ T cell response did develop. Thus, our work advocates for the development of dengue vaccine candidates that induce protective CD8+ T cells despite the presence of enhancing, interfering maternal antibodies.
- Published
- 2017
- Full Text
- View/download PDF
143. Early molecular correlates of adverse events following yellow fever vaccination.
- Author
-
Chan CY, Chan KR, Chua CJ, Nur Hazirah S, Ghosh S, Ooi EE, and Low JG
- Subjects
- Adult, Antibodies, Viral blood, Central Nervous System Diseases etiology, Central Nervous System Diseases genetics, Central Nervous System Diseases immunology, Female, Gene Expression Profiling methods, Humans, Immunity, Innate genetics, Immunity, Innate immunology, Male, Middle Aged, Musculoskeletal Diseases etiology, Musculoskeletal Diseases genetics, Musculoskeletal Diseases immunology, Up-Regulation immunology, Viremia immunology, Yellow Fever immunology, Yellow Fever virology, Yellow Fever Vaccine immunology, Yellow fever virus immunology, Yellow fever virus isolation & purification, Young Adult, Vaccination adverse effects, Yellow Fever prevention & control, Yellow Fever Vaccine adverse effects
- Abstract
The innate immune response shapes the development of adaptive immunity following infections and vaccination. However, it can also induce symptoms such as fever and myalgia, leading to the possibility that the molecular basis of immunogenicity and reactogenicity of vaccination are inseparably linked. To test this possibility, we used the yellow fever live-attenuated vaccine (YFLAV) as a model to study the molecular correlates of reactogenicity or adverse events (AEs). We analyzed the outcome of 68 adults who completed a YFLAV clinical trial, of which 43 (63.2%) reported systemic AEs. Through whole-genome profiling of blood collected before and after YFLAV dosing, we observed that activation of innate immune genes at day 1, but not day 3 after vaccination, was directly correlated with AEs. These findings contrast with the gene expression profile at day 3 that we and others have previously shown to be correlated with immunogenicity. We conclude that although the innate immune response is a double-edged sword, its expression that induces AEs is temporally distinct from that which engenders robust immunity. The use of genomic profiling thus provides molecular insights into the biology of AEs that potentially forms a basis for the development of safer vaccines.
- Published
- 2017
- Full Text
- View/download PDF
144. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
- Author
-
Costa VV, Ye W, Chen Q, Teixeira MM, Preiser P, Ooi EE, and Chen J
- Subjects
- Animals, Antigens, CD genetics, Antigens, Differentiation, T-Lymphocyte genetics, Cell Adhesion Molecules antagonists & inhibitors, Dendritic Cells immunology, Humans, Interferon-gamma immunology, Interferon-gamma metabolism, Interleukin-2 Receptor alpha Subunit genetics, Lectins, C-Type genetics, Liver pathology, Lymphocyte Activation, Mice, Mice, SCID, Monocytes immunology, Thrombocytopenia virology, Viremia, Virus Replication, Cell Adhesion Molecules metabolism, Dendritic Cells virology, Dengue immunology, Dengue Virus immunology, Killer Cells, Natural immunology, Monocytes virology
- Abstract
Natural killer (NK) cells play a protective role against dengue virus (DENV) infection, but the cellular and molecular mechanisms are not fully understood. Using an optimized humanized mouse model, we show that human NK cells, through the secretion of gamma interferon (IFN-γ), are critical in the early defense against DENV infection. Depletion of NK cells or neutralization of IFN-γ leads to increased viremia and more severe thrombocytopenia and liver damage in humanized mice. In vitro studies using autologous human NK cells show that DENV-infected monocyte-derived dendritic cells (MDDCs), but not monocytes, activate NK cells in a contact-dependent manner, resulting in upregulation of CD69 and CD25 and secretion of IFN-γ. Blocking adhesion molecules (LFA-1, DNAM-1, CD2, and 2β4) on NK cells abolishes NK cell activation, IFN-γ secretion, and the control of DENV replication. NK cells activated by infected MDDCs also inhibit DENV infection in monocytes. These findings show the essential role of human NK cells in protection against acute DENV infection in vivo , identify adhesion molecules and dendritic cells required for NK cell activation, and delineate the sequence of events for NK cell activation and protection against DENV infection. IMPORTANCE Dengue is a mosquito-transmitted viral disease with a range of symptoms, from mild fever to life-threatening dengue hemorrhagic fever. The diverse disease manifestation is thought to result from a complex interplay between viral and host factors. Using mice engrafted with a human immune system, we show that human NK cells inhibit virus infection through secretion of the cytokine gamma interferon and reduce disease pathogenesis, including depletion of platelets and liver damage. During a natural infection, DENV initially infects dendritic cells in the skin. We find that NK cells interact with infected dendritic cells through physical contact mediated by adhesion molecules and become activated before they can control virus infection. These results show a critical role of human NK cells in controlling DENV infection in vivo and reveal the sequence of molecular and cellular events that activate NK cells to control dengue virus infection., (Copyright © 2017 Costa et al.)
- Published
- 2017
- Full Text
- View/download PDF
145. Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates.
- Author
-
Ong EZ, Budigi Y, Tan HC, Robinson LN, Rowley KJ, Winnett A, Hobbie S, Shriver Z, Babcock GJ, and Ooi EE
- Subjects
- Animals, Drug Evaluation, Preclinical, Macaca, Treatment Outcome, Antibodies, Viral administration & dosage, Antiviral Agents administration & dosage, Dengue therapy, Dengue Virus immunology, Immunologic Factors administration & dosage, Immunotherapy methods
- Abstract
Despite useful in vivo activity, no therapeutic against dengue virus (DENV) has demonstrated efficacy in clinical trials. Herein, we explored dosing and virological endpoints to guide the design of human trials of VIS513, a pan-serotype anti-DENV IgG1 antibody, in non-human primates (NHPs). Dosing VIS513 pre- or post-peak viremia in NHPs neutralized infectious DENV although RNAemia remained detectable post-treatment; differential interaction of human IgGs with macaque Fc-gamma receptors may delay clearance of neutralized DENV. Our findings suggest useful antiviral utility of VIS513 and highlight an important consideration when evaluating virological endpoints of trials for anti-DENV biologics., (Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
146. Dengue subgenomic flaviviral RNA disrupts immunity in mosquito salivary glands to increase virus transmission.
- Author
-
Pompon J, Manuel M, Ng GK, Wong B, Shan C, Manokaran G, Soto-Acosta R, Bradrick SS, Ooi EE, Missé D, Shi PY, and Garcia-Blanco MA
- Subjects
- Animals, Dengue virology, Dengue Virus genetics, Humans, RNA, Viral genetics, RNA, Viral metabolism, Salivary Glands immunology, Salivary Glands virology, Virus Replication, Aedes immunology, Aedes virology, Dengue transmission, Dengue Virus physiology, Insect Vectors immunology, Insect Vectors virology
- Abstract
Globally re-emerging dengue viruses are transmitted from human-to-human by Aedes mosquitoes. While viral determinants of human pathogenicity have been defined, there is a lack of knowledge of how dengue viruses influence mosquito transmission. Identification of viral determinants of transmission can help identify isolates with high epidemiological potential. Additionally, mechanistic understanding of transmission will lead to better understanding of how dengue viruses harness evolution to cycle between the two hosts. Here, we identified viral determinants of transmission and characterized mechanisms that enhance production of infectious saliva by inhibiting immunity specifically in salivary glands. Combining oral infection of Aedes aegypti mosquitoes and reverse genetics, we identified two 3' UTR substitutions in epidemic isolates that increased subgenomic flaviviral RNA (sfRNA) quantity, infectious particles in salivary glands and infection rate of saliva, which represents a measure of transmission. We also demonstrated that various 3'UTR modifications similarly affect sfRNA quantity in both whole mosquitoes and human cells, suggesting a shared determinism of sfRNA quantity. Furthermore, higher relative quantity of sfRNA in salivary glands compared to midgut and carcass pointed to sfRNA function in salivary glands. We showed that the Toll innate immune response was preferentially inhibited in salivary glands by viruses with the 3'UTR substitutions associated to high epidemiological fitness and high sfRNA quantity, pointing to a mechanism for higher saliva infection rate. By determining that sfRNA is an immune suppressor in a tissue relevant to mosquito transmission, we propose that 3'UTR/sfRNA sequence evolution shapes dengue epidemiology not only by influencing human pathogenicity but also by increasing mosquito transmission, thereby revealing a viral determinant of epidemiological fitness that is shared between the two hosts.
- Published
- 2017
- Full Text
- View/download PDF
147. Serial Metabolome Changes in a Prospective Cohort of Subjects with Influenza Viral Infection and Comparison with Dengue Fever.
- Author
-
Cui L, Fang J, Ooi EE, and Lee YH
- Subjects
- Adult, Dengue diagnosis, Dengue virology, Dengue Virus pathogenicity, Dengue Virus physiology, Fatty Acids blood, Female, Gonadal Steroid Hormones blood, Gonadal Steroid Hormones genetics, Host-Pathogen Interactions, Humans, Influenza A Virus, H3N2 Subtype pathogenicity, Influenza A Virus, H3N2 Subtype physiology, Influenza, Human diagnosis, Influenza, Human virology, Lipoxygenase blood, Lipoxygenase genetics, Male, Middle Aged, Oxidation-Reduction, Phospholipids blood, Prospective Studies, Purines blood, Tryptophan blood, Dengue blood, Influenza, Human blood, Lipid Metabolism genetics, Metabolic Networks and Pathways genetics, Metabolome
- Abstract
Influenza virus infection (IVI) and dengue virus infection (DVI) are major public health threats. Between IVI and DVI, clinical symptoms can be overlapping yet infection-specific, but host metabolome changes are not well-described. Untargeted metabolomics and targeted oxylipinomic analyses were performed on sera serially collected at three phases of infection from a prospective cohort study of adult subjects with either H3N2 influenza infection or dengue fever. Untargeted metabolomics identified 26 differential metabolites, and major perturbed pathways included purine metabolism, fatty acid biosynthesis and β-oxidation, tryptophan metabolism, phospholipid catabolism, and steroid hormone pathway. Alterations in eight oxylipins were associated with the early symptomatic phase of H3N2 flu infection, were mostly arachidonic acid-derived, and were enriched in the lipoxygenase pathway. There was significant overlap in metabolome profiles in both infections. However, differences specific to IVI and DVI were observed. DVI specifically attenuated metabolites including serotonin, bile acids and biliverdin. Additionally, metabolome changes were more persistent in IVI in which metabolites such as hypoxanthine, inosine, and xanthine of the purine metabolism pathway remained significantly elevated at 21-27 days after fever onset. This study revealed the dynamic metabolome changes in IVI subjects and provided biochemical insights on host physiological similarities and differences between IVI and DVI.
- Published
- 2017
- Full Text
- View/download PDF
148. Serum Metabolomics Investigation of Humanized Mouse Model of Dengue Virus Infection.
- Author
-
Cui L, Hou J, Fang J, Lee YH, Costa VV, Wong LH, Chen Q, Ooi EE, Tannenbaum SR, Chen J, and Ong CN
- Subjects
- Animals, Disease Models, Animal, Mass Spectrometry, Metabolomics, Mice, Mice, SCID, Time Factors, Dengue pathology, Metabolome, Serum chemistry
- Abstract
Dengue is an acute febrile illness caused by dengue virus (DENV) and a major cause of morbidity and mortality in tropical and subtropical regions of the world. The lack of an appropriate small-animal model of dengue infection has greatly hindered the study of dengue pathogenesis and the development of therapeutics. In this study, we conducted mass spectrometry-based serum metabolic profiling from a model using humanized mice (humice) with DENV serotype 2 infection at 0, 3, 7, 14, and 28 days postinfection (dpi). Forty-eight differential metabolites were identified, including fatty acids, purines and pyrimidines, acylcarnitines, acylglycines, phospholipids, sphingolipids, amino acids and derivatives, free fatty acids, and bile acid. These metabolites showed a reversible-change trend-most were significantly perturbed at 3 or 7 dpi and returned to control levels at 14 or 28 dpi, indicating that the metabolites might serve as prognostic markers of the disease in humice. The major perturbed metabolic pathways included purine and pyrimidine metabolism, fatty acid β-oxidation, phospholipid catabolism, arachidonic acid and linoleic acid metabolism, sphingolipid metabolism, tryptophan metabolism, phenylalanine metabolism, lysine biosynthesis and degradation, and bile acid biosynthesis. Most of these disturbed pathways are similar to our previous metabolomics findings in a longitudinal cohort of adult human dengue patients across different infection stages. Our analyses revealed the commonalities of host responses to DENV infection between humice and humans and suggested that humice could be a useful small-animal model for the study of dengue pathogenesis and the development of dengue therapeutics. IMPORTANCE Dengue virus is the most widespread arbovirus, causing an estimated 390 million dengue infections worldwide every year. There is currently no effective treatment for the disease, and the lack of an appropriate small-animal model of dengue infection has greatly increased the challenges in the study of dengue pathogenesis and the development of therapeutics. Metabolomics provides global views of small-molecule metabolites and is a useful tool for finding metabolic pathways related to disease processes. Here, we conducted a serum metabolomics study on a model using humanized mice with dengue infection that had significant levels of human platelets, monocytes/macrophages, and hepatocytes. Forty-eight differential metabolites were identified, and the underlying perturbed metabolic pathways are quite similar to the pathways found to be altered in dengue patients in previous metabolomics studies, indicating that humanized mice could be a highly relevant small-animal model for the study of dengue pathogenesis and the development of dengue therapeutics., (Copyright © 2017 Cui et al.)
- Published
- 2017
- Full Text
- View/download PDF
149. Peridomestic Aedes malayensis and Aedes albopictus are capable vectors of arboviruses in cities.
- Author
-
Mendenhall IH, Manuel M, Moorthy M, Lee TTM, Low DHW, Missé D, Gubler DJ, Ellis BR, Ooi EE, and Pompon J
- Subjects
- Animals, Cities, Entomology, Humans, Singapore, Aedes growth & development, Aedes virology, Chikungunya virus isolation & purification, Dengue Virus isolation & purification, Mosquito Vectors growth & development, Mosquito Vectors virology, Saliva virology
- Abstract
Background: Dengue and chikungunya are global re-emerging mosquito-borne diseases. In Singapore, sustained vector control coupled with household improvements reduced domestic mosquito populations for the past 45 years, particularly the primary vector Aedes aegypti. However, while disease incidence was low for the first 30 years following vector control implementation, outbreaks have re-emerged in the past 15 years. Epidemiological observations point to the importance of peridomestic infection in areas not targeted by control programs. We investigated the role of vectors in peri-domestic areas., Methods: We carried out entomological surveys to identify the Aedes species present in vegetated sites in highly populated areas and determine whether mosquitoes were present in open-air areas frequented by people. We compared vector competence of Aedes albopictus and Aedes malayensis with Ae. aegypti after oral infection with sympatric dengue serotype 2 and chikungunya viruses. Mosquito saliva was tested for the presence of infectious virus particles as a surrogate for transmission following oral infection., Results: We identified Aedes albopictus and Aedes malayensis throughout Singapore and quantified their presence in forested and opened grassy areas. Both Ae. albopictus and Ae. malayensis can occupy sylvatic niches and were highly susceptible to both arboviruses. A majority of saliva of infected Ae. malayensis contained infectious particles for both viruses., Conclusions: Our study reveals the prevalence of competent vectors in peri-domestic areas, including Ae. malayensis for which we established the vector status. Epidemics can be driven by infection foci, which are epidemiologically enhanced in the context of low herd immunity, selective pressure on arbovirus transmission and the presence of infectious asymptomatic persons, all these conditions being present in Singapore. Learning from Singapore's vector control success that reduced domestic vector populations, but has not sustainably reduced arboviral incidence, we suggest including peri-domestic vectors in the scope of vector management.
- Published
- 2017
- Full Text
- View/download PDF
150. Dengue virus activates cGAS through the release of mitochondrial DNA.
- Author
-
Sun B, Sundström KB, Chew JJ, Bist P, Gan ES, Tan HC, Goh KC, Chawla T, Tang CK, and Ooi EE
- Subjects
- Animals, Cell Line, Cricetinae, Epithelial Cells immunology, Humans, DNA, Mitochondrial metabolism, Dengue Virus growth & development, Dengue Virus immunology, Immunity, Innate, Nucleotidyltransferases metabolism, Receptors, Immunologic metabolism
- Abstract
Cyclic GMP-AMP synthetase (cGAS) is a DNA-specific cytosolic sensor, which detects and initiates host defense responses against microbial DNA. It is thus curious that a recent study identified cGAS as playing important roles in inhibiting positive-sense single-stranded RNA (+ssRNA) viral infection, especially since RNA is not known to activate cGAS. Using a dengue virus serotype 2 (DENV-2) vaccine strain (PDK53), we show that infection creates an endogenous source of cytosolic DNA in infected cells through the release of mitochondrial DNA (mtDNA) to drive the production of cGAMP by cGAS. Innate immune responses triggered by cGAMP contribute to limiting the spread of DENV to adjacent uninfected cells through contact dependent gap junctions. Our result thus supports the notion that RNA virus indirectly activates a DNA-specific innate immune signaling pathway and highlights the breadth of the cGAS-induced antiviral response.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.